It has been reported that inhibition of SHP2 promotes mesenchymal-to-epithelial transformation in breast cancer cells (40), which was consistent with our current finding that SHP2 promoted EMT in lung epithelial cells. The gene discussed is PTPN11; the disease is breast cancer.